We are live on ! Find out more
BBNX

Beta Bionics

158 hedge funds and large institutions have $1.44B invested in Beta Bionics in 2025 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 61 increasing their positions, 30 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 16

103% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 30

50% more capital invested

Capital invested by funds: $963M → $1.44B (+$477M)

22% more funds holding

Funds holding: 129158 (+29)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

3.96% less ownership

Funds ownership: 111.22%107.26% (-4%)

Holders
158
Holders Change
+29
Holders Change %
+22.48%
% of All Funds
1.92%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
46
Increased
61
Reduced
30
Closed
16
Calls
$320K
Puts
Net Calls
+$320K
Net Calls Change
+$320K
Name Holding Trade Value Shares
Change
Change in
Stake
VFA
76
Values First Advisors
Tennessee
$1.07M -$141K -5,274 -13%
LIP
77
Lighthouse Investment Partners
Florida
$1.07M +$935K +35,000 New
N
78
Numerai
California
$1.04M +$916K +34,285 New
Ameriprise
79
Ameriprise
Minnesota
$988K -$82.3K -3,081 -9%
QCM
80
Quantinno Capital Management
New York
$971K +$141K +5,273 +20%
EAM
81
Evanson Asset Management
California
$953K -$66.8K -2,500 -7%
VOYA Investment Management
82
VOYA Investment Management
Georgia
$925K +$811K +30,366 New
Vontobel Holding
83
Vontobel Holding
Switzerland
$736K +$645K +24,152 New
MIM
84
MetLife Investment Management
New Jersey
$692K
DFCM
85
Dark Forest Capital Management
Puerto Rico
$637K -$944K -35,353 -63%
Mariner
86
Mariner
Kansas
$630K -$19.1K -717 -3%
GCP
87
GSA Capital Partners
United Kingdom
$571K +$104K +3,888 +26%
Qube Research & Technologies (QRT)
88
Qube Research & Technologies (QRT)
United Kingdom
$530K +$464K +17,378 New
Fidelity Investments
89
Fidelity Investments
Massachusetts
$521K +$8.04K +301 +2%
Susquehanna International Group
90
Susquehanna International Group
Pennsylvania
$452K +$396K +14,833 New
GIA
91
Gladstone Institutional Advisory
Florida
$433K
SPC
92
Sigma Planning Corp
Michigan
$411K +$360K +13,500 New
ZCI
93
Zevenbergen Capital Investments
Washington
$407K +$356K +13,350 New
D.E. Shaw & Co
94
D.E. Shaw & Co
New York
$400K +$351K +13,142 New
IIM
95
INTECH Investment Management
Florida
$393K +$344K +12,891 New
Bank of Montreal
96
Bank of Montreal
Ontario, Canada
$392K +$70.4K +2,636 +26%
New York State Common Retirement Fund
97
New York State Common Retirement Fund
New York
$372K
CG
98
Caprock Group
Idaho
$369K +$47.2K +1,769 +17%
American Century Companies
99
American Century Companies
Missouri
$366K +$321K +12,024 New
Brown Advisory
100
Brown Advisory
Maryland
$364K

BBNX Hedge Fund Activity: Q4 2025 in Review

158 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Beta Bionics (BBNX) for Q4 2025, worth a combined $1.44B — up 50% from $963M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new BBNX positions and 16 closed out — a net gain of 30 holders — while 61 added to existing stakes and 30 trimmed.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $35.4M. The largest seller was Wellington Management Group, exiting entirely with an estimated $77.5M sold.

  • 158 institutional investors held Beta Bionics (BBNX) as of Q4 2025, up from 129 in Q3 2025.
  • Funds reported $1.44B of Beta Bionics stock for Q4 2025, up 50% quarter-over-quarter.
  • 46 funds opened new Beta Bionics positions in Q4 2025 and 16 closed out, a net change of +30 holders.
  • The largest Beta Bionics buyer in Q4 2025 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $35.4M added.
  • The largest Beta Bionics seller in Q4 2025 was Wellington Management Group, an estimated $77.5M sold.

Based on aggregated 13F filings for Q4 2025.